Samyang Biopharmaceuticals Corporation

This study tests a new injectable called DMFI300 for treating nasolabial folds (the lines from nose to mouth corners). Thirty adults will receive DMFI300 on one side of the face and a comparator filler on the other. Researchers will check wrinkle severity and safety over 12 month…

This study tests a device called DMFI150 to see if it can safely reduce the deep wrinkles from nose to mouth (nasolabial folds). 30 adults aged 18-70 with moderate to severe wrinkles will get one treatment. Doctors will check wrinkle improvement and safety for up to 12 months.